Logo image of AMC.DE

ALBEMARLE CORP (AMC.DE) Stock Fundamental Analysis

FRA:AMC - Deutsche Boerse Ag - US0126531013 - Common Stock - Currency: EUR

70.88  +1.26 (+1.81%)

Fundamental Rating

3

Taking everything into account, AMC scores 3 out of 10 in our fundamental rating. AMC was compared to 61 industry peers in the Chemicals industry. AMC may be in some trouble as it scores bad on both profitability and health. AMC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AMC has reported negative net income.
AMC had a positive operating cash flow in the past year.
Of the past 5 years AMC 4 years were profitable.
In the past 5 years AMC always reported a positive cash flow from operatings.
AMC.DE Yearly Net Income VS EBIT VS OCF VS FCFAMC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

AMC has a Return On Assets of -7.92%. This is in the lower half of the industry: AMC underperforms 69.84% of its industry peers.
AMC has a Return On Equity of -13.21%. This is in the lower half of the industry: AMC underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -7.92%
ROE -13.21%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
AMC.DE Yearly ROA, ROE, ROICAMC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

AMC's Gross Margin of 1.19% is on the low side compared to the rest of the industry. AMC is outperformed by 84.13% of its industry peers.
AMC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
AMC.DE Yearly Profit, Operating, Gross MarginsAMC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

3

2. Health

2.1 Basic Checks

AMC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMC has about the same amount of shares outstanding.
Compared to 5 years ago, AMC has more shares outstanding
AMC has a better debt/assets ratio than last year.
AMC.DE Yearly Shares OutstandingAMC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMC.DE Yearly Total Debt VS Total AssetsAMC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.61, we must say that AMC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.61, AMC is doing worse than 66.67% of the companies in the same industry.
AMC has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
AMC has a Debt to Equity ratio of 0.31. This is in the better half of the industry: AMC outperforms 68.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.61
ROIC/WACCN/A
WACC7.91%
AMC.DE Yearly LT Debt VS Equity VS FCFAMC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

AMC has a Current Ratio of 1.95. This is a normal value and indicates that AMC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AMC (1.95) is better than 63.49% of its industry peers.
AMC has a Quick Ratio of 1.19. This is a normal value and indicates that AMC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.19, AMC is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.19
AMC.DE Yearly Current Assets VS Current LiabilitesAMC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

AMC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.52%.
Looking at the last year, AMC shows a very negative growth in Revenue. The Revenue has decreased by -44.08% in the last year.
The Revenue has been growing by 8.42% on average over the past years. This is quite good.
EPS 1Y (TTM)-110.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-158.92%
Revenue 1Y (TTM)-44.08%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-47.72%

3.2 Future

AMC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.51% yearly.
Based on estimates for the next years, AMC will show a quite strong growth in Revenue. The Revenue will grow by 14.01% on average per year.
EPS Next Y79.84%
EPS Next 2Y74.44%
EPS Next 3Y59.2%
EPS Next 5Y71.51%
Revenue Next Year-7.44%
Revenue Next 2Y2.34%
Revenue Next 3Y6.22%
Revenue Next 5Y14.01%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMC.DE Yearly Revenue VS EstimatesAMC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AMC.DE Yearly EPS VS EstimatesAMC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMC. In the last year negative earnings were reported.
Also next year AMC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMC.DE Price Earnings VS Forward Price EarningsAMC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMC.DE Per share dataAMC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as AMC's earnings are expected to grow with 59.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.44%
EPS Next 3Y59.2%

More info and screens

4

5. Dividend

5.1 Amount

AMC has a Yearly Dividend Yield of 2.12%.
The stock price of AMC dropped by -28.38% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.89, AMC has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, AMC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

On average, the dividend of AMC grows each year by 13.04%, which is quite nice.
Dividend Growth(5Y)13.04%
Div Incr Years3
Div Non Decr Years3
AMC.DE Yearly Dividends per shareAMC.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AMC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of AMC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-23.65%
EPS Next 2Y74.44%
EPS Next 3Y59.2%
AMC.DE Yearly Income VS Free CF VS DividendAMC.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

FRA:AMC (3/7/2025, 7:00:00 PM)

70.88

+1.26 (+1.81%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners99.62%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap8.33B
Analysts68.13
Price Target96.13 (35.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend2.44
Dividend Growth(5Y)13.04%
DP-23.65%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-151.9%
Min EPS beat(2)-249.28%
Max EPS beat(2)-54.53%
EPS beat(4)0
Avg EPS beat(4)-99.35%
Min EPS beat(4)-249.28%
Max EPS beat(4)-3.3%
EPS beat(8)3
Avg EPS beat(8)-29.85%
EPS beat(12)7
Avg EPS beat(12)-15.03%
EPS beat(16)11
Avg EPS beat(16)-6.38%
Revenue beat(2)0
Avg Revenue beat(2)-5.48%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-2.26%
Revenue beat(4)2
Avg Revenue beat(4)-0.58%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)5.88%
Revenue beat(8)3
Avg Revenue beat(8)-1.78%
Revenue beat(12)4
Avg Revenue beat(12)-1.45%
Revenue beat(16)6
Avg Revenue beat(16)-0.36%
PT rev (1m)-9.57%
PT rev (3m)-11.13%
EPS NQ rev (1m)-29.04%
EPS NQ rev (3m)-57.28%
EPS NY rev (1m)-205.46%
EPS NY rev (3m)-146.3%
Revenue NQ rev (1m)-8.32%
Revenue NQ rev (3m)-9.24%
Revenue NY rev (1m)-5.95%
Revenue NY rev (3m)-8.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.68
P/FCF N/A
P/OCF 12.89
P/B 0.91
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-2.16
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-7.71
FCFYN/A
OCF(TTM)5.5
OCFY7.76%
SpS42.13
BVpS78.04
TBVpS63.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.92%
ROE -13.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.19%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 286.39%
Cap/Sales 31.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.19
Altman-Z 1.61
F-Score4
WACC7.91%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-158.92%
EPS Next Y79.84%
EPS Next 2Y74.44%
EPS Next 3Y59.2%
EPS Next 5Y71.51%
Revenue 1Y (TTM)-44.08%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-47.72%
Revenue Next Year-7.44%
Revenue Next 2Y2.34%
Revenue Next 3Y6.22%
Revenue Next 5Y14.01%
EBIT growth 1Y-237.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year165.75%
EBIT Next 3Y59.57%
EBIT Next 5Y40.31%
FCF growth 1Y-19.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.03%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%